EU
Emory University Portfolio holdings
AUM
$27.7M
1-Year Return
31.53%
This Quarter Return
+4.14%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$113M
AUM Growth
+$7.25M
(+6.8%)
Cap. Flow
+$7.7M
Cap. Flow
% of AUM
6.8%
Top 10 Holdings %
Top 10 Hldgs %
42.19%
Holding
57
New
16
Increased
8
Reduced
26
Closed
5
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$2.74M |
| 2 |
Esperion Therapeutics
ESPR
|
$2.16M |
| 3 |
Amicus Therapeutics
FOLD
|
$2.04M |
| 4 |
NXTM
NxStage Medical Inc.
NXTM
|
$1.8M |
| 5 |
Travere Therapeutics
TVTX
|
$1.77M |
Top Sells
| 1 |
Ardelyx
ARDX
|
$2.4M |
| 2 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$2.03M |
| 3 |
LPL Financial
LPLA
|
$1.59M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$1.54M |
| 5 |
Trinity Industries
TRN
|
$1.54M |
Sector Composition
| 1 | Healthcare | 43.85% |
| 2 | Financials | 32.05% |
| 3 | Technology | 5.46% |
| 4 | Energy | 4.39% |
| 5 | Consumer Discretionary | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Willis Towers Watson
WTW
$32.1B
| $1.61M | 1.42% |
11,041
-1,958
| -15% | -$285K |
|
|
TFCF
27
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $1.6M | 1.42% |
57,553
+3,351
| +6% | +$93.4K |
|
28
Microsoft
MSFT
$3.77T
| $1.6M | 1.42% |
23,239
-2,506
| -10% | -$173K |
|
29
BioCryst Pharmaceuticals
BCRX
$1.73B
| $1.6M | 1.41% |
287,550
-87,798
| -23% | -$488K |
|
30
Acadia Pharmaceuticals
ACAD
$4.31B
| $1.59M | 1.4% |
56,923
+788
| +1% | +$22K |
|
31
Viasat
VSAT
$3.92B
| $1.59M | 1.4% |
23,955
-298
| -1% | -$19.7K |
|
|
DBVT
32
DBV Technologies
DBVT
$254M
| $1.59M | 1.4% |
4,439
-1,849
| -29% | -$660K |
|
33
Sarepta Therapeutics
SRPT
$1.93B
| $1.58M | 1.4% |
+46,979
| New | +$1.58M |
|
34
Axalta
AXTA
$6.71B
| $1.58M | 1.4% |
+49,331
| New | +$1.58M |
|
|
LVNTA
35
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $1.58M | 1.39% |
30,156
-6,942
| -19% | -$363K |
|
36
BioMarin Pharmaceuticals
BMRN
$10.9B
| $1.57M | 1.39% |
17,330
-6,461
| -27% | -$587K |
|
37
CommScope
COMM
$3.6B
| $1.57M | 1.39% |
41,320
-552
| -1% | -$21K |
|
38
Kinder Morgan
KMI
$59.3B
| $1.52M | 1.34% |
79,457
+7,268
| +10% | +$139K |
|
39
Arch Capital
ACGL
$34.5B
| $1.52M | 1.34% |
48,882
-3,606
| -7% | -$112K |
|
|
MYOV
40
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.51M | 1.34% |
+129,228
| New | +$1.51M |
|
41
Xencor
XNCR
$601M
| $1.49M | 1.32% |
+70,640
| New | +$1.49M |
|
42
Neurogene
NGNE
$281M
| $1.49M | 1.32% |
5,291
-312
| -6% | -$87.8K |
|
|
BHI
43
DELISTED
Baker Hughes
BHI
| $1.47M | 1.29% |
26,867
+410
| +2% | +$22.4K |
|
44
Incyte
INCY
$16.7B
| $1.46M | 1.29% |
11,570
-6,023
| -34% | -$758K |
|
|
GBT
45
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.44M | 1.27% |
+52,709
| New | +$1.44M |
|
46
Seagate
STX
$38.3B
| $1.42M | 1.25% |
36,573
+2,568
| +8% | +$99.5K |
|
|
LJPC
47
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.41M | 1.25% |
+47,353
| New | +$1.41M |
|
|
AKAO
48
DELISTED
Achaogen, Inc.
AKAO
| $1.4M | 1.24% |
+64,513
| New | +$1.4M |
|
49
Wave Life Sciences
WVE
$1.26B
| $1.38M | 1.22% |
74,020
+477
| +0.6% | +$8.87K |
|
50
Neurocrine Biosciences
NBIX
$13.7B
| $1.35M | 1.19% |
+29,316
| New | +$1.35M |
|